Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Wagner Insider Profile
11 Followers
Paul Wagner, CFO at Pfenex, holds 0.00 shares in Pfenex (Ticker: PFNX), holds 77.47K shares in Forte Biosciences (Ticker: FBRX). Most recently, Paul Wagner ― shares of Pfenex on ― for an estimated value of ―.
Profitable Transactions
7 out of 8 Profitable Transactions
Average Return
+46.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Secretary and Chair of the Board, Director
Roles that Paul Wagner holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul Wagner
Paul Wagner's Trading History
Pfenex
―
―
―
$0.00
Forte Biosciences
Oct 02, 2024
CEO, Secretary and Chair of the Board, Director
Uninformative Buy
5.94K
$1.50M
List of latest transactions for each holding click on a transaction to see Paul Wagner's performance on stock
You May Also Like
Paul Wagner insider profile FAQ
What is the percentage of profitable transactions made by Paul Wagner?
The percentage of profitable transactions made by Paul Wagner is 88%.
What is the average return per transaction made by Paul Wagner?
The average return per transaction made by Paul Wagner is 46.60%.
What stocks does Paul Wagner hold?
Paul Wagner holds: PFNX, FBRX stocks.
What was Paul Wagner’s latest transaction?
Paul Wagner latest transaction was an Uninformative Buy of ―.
What was Paul Wagner's most profitable transaction?
Paul Wagner’s most profitable transaction was an Informative Buy of FBRX stock on June 29, 2020. The return on the trade was 130.80%.
What is Paul Wagner's role in Pfenex?
Paul Wagner's role in Pfenex is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.